Cynthia Sirard
Vermögen: 31 075 $ am 31.05.2026
Vermögen: 31 075 $ am 31.05.2026
Cynthia Sirard is Chief Medical Officer at Compass Therapeutics, Inc. since 2026.
Formerly, Dr. Sirard was Chief Medical Officer at Cypherpunk Technologies, Inc. from 2020 to 2025 and Medical Director at PAREXEL International Corp.
from 2003 to 2005.
Education includes undergraduate studies at the University of Massachusetts and a doctorate from Chicago Medical School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 27.500 ( 0,03 % ) | 31 075 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.07.2025 |
| PAREXEL INTERNATIONAL CORPORATION | Corporate Officer/Principal | 01.01.2005 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
PAREXEL International Corp.
PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
University of Massachusetts
University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chicago Medical School
Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leap Therapeutics, Inc.
Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
Compass Therapeutics, Inc.
Compass Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage oncology biopharmaceutical company that develops antibody based therapeutics to treat multiple human diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen